![Augusto Ocana](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Karriereverlauf von Augusto Ocana
Ehemalige bekannte Positionen von Augusto Ocana
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
MEDITE CANCER DIAGNOSTICS INC | Direktor/Vorstandsmitglied | 01.11.2006 | 23.01.2018 |
C.H. Werfen, Inc. | Direktor/Vorstandsmitglied | 01.01.1999 | 01.01.2006 |
CytoCore, Inc.
![]() CytoCore, Inc. Medical SpecialtiesHealth Technology CytoCore, Inc. develops, manufactures and sells an integrated family of products for the detection, diagnosis and treatment of cancer. The company markets its products under the trade name CytoCore Solutions, which is intended to address sample collection, specimen preparation, specimen evaluation, including detection/screening and diagnosis, treatment and patient monitoring within vertical markets related to specific cancers. The company also designs, markets and sells a companion product to detect breast cancer. It intends to focus on the expansion of its products for the treatment of gynecological cancer as well as bladder, lung, and breast cancers amongst others. CytoCore was founded in December 1998 and is headquartered in Chicago, IL. | Direktor/Vorstandsmitglied | 01.03.2012 | - |
Statistik
International
Vereinigte Staaten | 4 |
Operativ
Director/Board Member | 3 |
Sektoral
Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
MEDITE CANCER DIAGNOSTICS INC | Health Technology |
Private Unternehmen | 2 |
---|---|
CytoCore, Inc.
![]() CytoCore, Inc. Medical SpecialtiesHealth Technology CytoCore, Inc. develops, manufactures and sells an integrated family of products for the detection, diagnosis and treatment of cancer. The company markets its products under the trade name CytoCore Solutions, which is intended to address sample collection, specimen preparation, specimen evaluation, including detection/screening and diagnosis, treatment and patient monitoring within vertical markets related to specific cancers. The company also designs, markets and sells a companion product to detect breast cancer. It intends to focus on the expansion of its products for the treatment of gynecological cancer as well as bladder, lung, and breast cancers amongst others. CytoCore was founded in December 1998 and is headquartered in Chicago, IL. | Health Technology |
C.H. Werfen, Inc. |
- Börse
- Insiders
- Augusto Ocana
- Erfahrung